Product Information

TAZAROTENE 0.1% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $6.3355 per GM under NDC 45802044294. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Apr 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TAZAROTENE 0.1% GEL

tazarotene
$6.3355per GM

Strength

1 mg/g

NDC

45802044294

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

TAZAROTENE

Approval Type

Generic (ANDA)

FDA Application

ANDA213079

FDA Approved

4/25/2023

TE Code

AB

On Market Since

6/5/2023

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for TAZAROTENE 0.1% GEL has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.

Current price$6.3355 per GM
All-time high$9.4818 (Jun 12, 2024)
All-time low$6.3355 (Nov 18, 2026)
52-week high$8.4457
52-week low$6.3355
Median price$8.3000
Average price$8.0648
Largest weekly change-9.7% (Jun 19, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

-0.2%

1M

-2.6%

3M

-2.8%

6M

-12.8%

1Y

-21.2%

3Y

N/A

5Y

N/A

All

-32.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TAZAROTENE 0.1% GEL?

The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.1% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $6.3355 per GM (NDC 45802044294), effective Nov 18, 2026.

How has the price of TAZAROTENE 0.1% GEL changed over time?

Over the history we have for it, the NADAC for TAZAROTENE 0.1% GEL has declined 32.4%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.1% GEL?

Since Apr 17, 2024, the NADAC for TAZAROTENE 0.1% GEL has ranged from a low of $6.3355 (Nov 18, 2026) to a high of $9.4818 (Jun 12, 2024), with a median of $8.3000 per GM.

Are there cheaper alternatives to TAZAROTENE 0.1% GEL?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TAZAROTENE 0.1% GEL in a comparable dosage form, but none are currently priced below it.

Who manufactures TAZAROTENE 0.1% GEL?

TAZAROTENE 0.1% GEL (NDC 45802044294) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.